Pediatrix Medical Group, Inc.

88
Strong Buy
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US58502B1061
USD
22.29
-1 (-4.29%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Pediatrix Medical Group, Inc. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
-101.00
-48.00
81.00
135.00
7.00
58.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
88.00
-11.00
31.00
-23.00
52.00
16.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
206.00
137.00
166.00
76.00
204.00
357.00
Cash Flow from Investing Activities
-35.00
-48.00
-56.00
-53.00
815.00
102.00
Cash Flow from Financing Activities
-14.00
-25.00
-487.00
-760.00
-4.00
-393.00
Net Cash Inflow / Outflow
156.00
63.00
-377.00
-736.00
1,015.00
67.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in USD Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Pediatrix Medical Group, Inc.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Profit Before Tax
-101.341
-10.362
-91.00
-878.01%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
88.239
32.175
56.00
174.25%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
206.573
-183.489
389.00
212.58%
Cash Flow from Investing Activities
-35.406
352.214
-387.00
-110.05%
Cash Flow from Financing Activities
-14.485
184.166
-198.00
-107.87%
Net Cash Inflow / Outflow
156.682
349.734
-193.00
-55.20%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
-3.157
3.00
100.00%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 50.43% vs -17.74% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
206.57
137.32
50.43%